Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

GSK Pharma Slapped Rs 38.06 Cr Decree by Bombay Court in Legacy Property Dispute

GSK Depemokimab accepted for review by EMA for use in asthma with type 2 inflammation, CRSwNP

Ruchika Sharma29 Jan 2025 2:30 PM IST

London: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application for...

Novo Nordisk Wegovy approved by USFDA for adults with noncirrhotic MASH with liver fibrosis

Novo Nordisk Ozempic get USFDA nod for reduction of kidney disease worsening risk, cardiovascular death in adults with type 2 diabetes, chronic kidney disease

Ruchika Sharma29 Jan 2025 1:30 PM IST

Plainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic to reduce the risk of kidney disease...

Cipla elevates Achin Gupta as new Global Chief Operating Officer

Ruchika Sharma29 Jan 2025 1:16 PM IST

Mumbai: Cipla has announced the appointment of Achin Gupta, Chief Executive Officer - One India Business (SMP) as the Global Chief Operating Officer...

Lupin unveils Risperidone Long Acting Injectable in US

Lupin, Avas unveil myotonia treatment NaMuscla in Italy

Ruchika Sharma29 Jan 2025 11:30 AM IST

Mumbai: Global pharma major Lupin Limited and Avas Pharmaceuticals SRL have announced the launch of Lupin's orphan drug NaMuscla (mexiletine) in...

Cipla, Hetero win bid to supply widely prescribed diabetes drug in China

33 year old man dies after taking under trial medication

Ruchika Sharma28 Jan 2025 5:10 PM IST

Bengaluru: A 33-year-old man died at his brother's home in Jalahalli after taking under trial medication. He had been involved in a clinical...

Inside Coldrif Scandal: Tamil Nadu Plant Used Paint-Grade Chemicals, Violated 300+ Drug Norms

Phensedyl cough syrup worth over Rs 1.4 crore seized in Nadia

Ruchika Sharma28 Jan 2025 3:30 PM IST

Nadia: The Border Security Force (BSF) South Bengal Frontier seized 62,200 bottles of Phensedyl cough syrup worth over Rs 1.4 crore. The seizure...

AstraZeneca Faces NPPA Heat Over Symbicort Pricing, Slapped Rs 60 Crore Showcause Notice

AstraZeneca-Daiichi Sankyo Enhertu gets USFDA approval for HER2-ultralow metastatic breast cancer

Ruchika Sharma28 Jan 2025 2:30 PM IST

AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with...

Affordable medicines for Mahakumbh Pilgrims: Jan Aushadhi centers set up in Nagar

Ruchika Sharma28 Jan 2025 1:30 PM IST

New Delhi: Five Jan Aushadhi centers have been set up in Mahakumbh Nagar, with one located in Kalagram, under the Pradhan Mantri Bhartiya...

Strides Pharma Science arm New York facility gets 4 USFDA observations

Aurobindo Pharma arm gets USFDA EIR for Telangana unit

Ruchika Sharma28 Jan 2025 12:30 PM IST

Telangana: Aurobindo Pharma has announced that the United States Food and Drug Administration (US FDA) has issued an Establishment...

Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology Deal

Merck WELIREG gets USFDA priority review for Advanced Pheochromocytoma and Paraganglioma

Ruchika Sharma28 Jan 2025 11:15 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...

$GSK Blenrep combos receive positive EMA Committee opinion in relapsed/refractory multiple myeloma$

GSK Shingrix new prefilled syringe presentation accepted for review by EMA

Ruchika Sharma28 Jan 2025 10:15 AM IST

London: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe...

USFDA nod to Leqembi IV maintenance dosing for treatment of early Alzheimer's Disease: Eisai, Biogen

Ruchika Sharma27 Jan 2025 12:22 PM IST

Tokyo: Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved the Supplemental...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok